Ketorolac Tromethamine/Phenylephrine Hydrochloride

酮咯酸氨丁三醇/盐酸去氧肾上腺素

Report date: 2022/01/14 13:23:58

Base Information

Drug NameKetorolac Tromethamine/Phenylephrine Hydrochloride
Drug Alias Name盐酸去氧肾上腺素/酮咯酸氨丁三醇ketorolac tromethamine and phenylephrineKetorolac trometamol/Phenylephrine HydrochlorideKetorolac Tromethamine/PhenylephrineKetorolac/Phenylephrine +[11] 
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenase-1 inhibitorsAdrenergic receptor alpha-1 agonistsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Adrenergic receptors alpha-1Cyclooxygenase-1
Therapy Area/IndicationsPain, PostoperativeCataractMiosis
Global Approved IndicationsPain, PostoperativeMiosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2014/05/30
Country/TerritoryUnited StatesEU
CombinationsYes Ketorolac TromethaminePhenylephrine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesOmeros Corp
China Registration ClassN/A

Develop Information

Active CompaniesDHS Consulting LLCRayner Surgical Ireland LtdOmeros Corp
Inactive CompaniesN/A
Active IndicationsPain, PostoperativeCataractMiosis
Inactive IndicationsN/A

Other Information

ATC CodeS01FB51
Related LinksKEGG